MENS jyongbio.com: Company Cash on Hand

MENS (Jyong Biotech Corp) - company brandmark

Revenue dynamics for Jyong Biotech Ltd (MENS) are based on the commercialization of the botanical agent MCS-2 for the treatment of BPH. Growth relies on the success of clinical trials and patent protection, while the environmental profile is limited to basic waste disposal. Changes in the cash balance demonstrate liquidity for investments, and the 0.00 metric confirms the company's current level of available capital.

MENS - Jyong Biotech Limited Company Cash Funds over the range 06/18/2025 - 11/21/2026

Summary analytical data breakdowns for Jyong Biotech Corp (MENS)

- stock quotes and analyst forecast:
Summary company analysis:Jyong Biotech Limited
Signature product of Jyong Biotech Limited

For Jyong Biotech Ltd (MENS), the volume of liquid assets determines the ability to fund the expansion of plant-based pharmaceuticals into Asian pharmacy chains without the risk of a cash crunch. An analysis of cash capital levels, reflecting the aggregate of cash and cash equivalents, allows investors to assess the balance between operational resilience and asset utilization efficiency during the business scaling period.

Competitors of Jyong Biotech Ltd (MENS)

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|LGND: Company Cash and Cash Equivalents|AMRX: Company Cash on Hand|Company Cash Reserve Perrigo Company plc|ALVO: Company Cash Volume|Liquidia (LQDA) - Company Cash Volume|Company Cash Funds Galapagos N.V.|Company Cash on Hand ANI Pharmaceuticals, Inc. (ANIP)|Company Cash Volume MNKD|AMPH (Amphastar Corp) - Company Cash Balance|Company Cash Funds pacira.com PCRX|SPRY - Company Cash on Hand|Theravance Biopharma, Inc. - Company Cash Volume|Company Cash Balance AQST (Aquestive Therapeutics, Inc.)|SCPH: Company Cash Volume|Tectonic Therapeutic Inc. - Company Cash Balance|TNXP (Tonix Pharma) - Company Cash Volume|SXTC: Company Cash Balance|Company Cash Volume EPRX|BHST - Company Cash Reserve|eXoZymes - Company Cash on Hand|Company Cash Volume oramed.com ORMP|ENTX - Company Cash Funds|Company Liquid Assets MindWalk Holdings HYFT|ABVC: Company Cash Volume|Company Cash on Hand Cumberland Pharmaceuticals Inc.|Company Cash Funds Quantum BioPharma Limited|FGEN: Company Cash Balance|Company Cash Volume TELO|Rani Therapeutics Holdings, Inc. - Company Cash and Cash Equivalents|Company Cash Funds Synergy CHC Corp. SNYR|Company Cash Balance RLYB|LEXX: Company Cash on Hand|Company Cash Balance PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Company Cash Funds|Company Cash on Hand Aptorum|Company Cash on Hand LYRA|Impact BioMedical Inc - Company Total Cash Volume|Company Cash Volume TNFA|YCBD - Company Cash Reserve|PainReform Ltd. - Company Cash on Hand|CYTO (Auris Medical) - Company Total Cash Volume|LIPO - Company Cash Funds|Company Cash Balance OPTN (OptiNose)|PIRS: Company Cash Volume|Procaps Group S.A. (PROC) - Company Cash Volume|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance